פרמקולוגיה מצגת מספר 1 (1)

  • View
    871

  • Download
    5

Embed Size (px)

Text of פרמקולוגיה מצגת מספר 1 (1)

1:: -9871. " , " / . : : . - , , - , ...- - " : ( ) - . : , ( ), , ,IV,IM, . : , , , ...., , . : : . : ,ATP . -pH & pKa . ()- IV . - - efficacy . . ( ) ( , ). - . , . , ( ) . : ( )first pass effect .

Vd=D/C D C Vd . - : 1 -Phase " ,OH, NH2, SH . 2 -Phase glucuronic acid, sulfuric acid, acetic acid, amino acid - . - , , . :IV s.s . S.S . 5t .S.S , .

S.S loading dose" .Loading dose=Vd*C

2: , ( , :Drug- Receptor Interaction ( , ...) , " " " " - . *- " " . : -Regulatory proteins " , . -Enzymes " -Transport proteins Na/K ATPase " . " Structural proteins tubulin . - . -Agonist " ).(allosteric effect - . .

-A: , . -G-protein -B , , . . G () G (). . -C - , . ( ) .

, " . -Intracellular receptors -D , .DNA DNA . " . . : . )05 -Effective concentration 50% (Ec ( )log %05 . : -Y -X . 05 Ec . :Potency KD ( 05.)Ec -Efficacy . ( efficacy .partial agonist TI :TI %05 )05 (Lc50/LD %05 )05 .(Ec50/ED . warfarin . - " . " . : : , , Emax . : " . . Emax - Emax. : . : . : . , . . . . : . .- .

. : , . () . : ,GI , SC /IM . ( ) %08 %56 . . , .: . , GI , , . . CNS .hangover . .orthostatic hypotension( ). : GI . IM . . .: , , , .: . . : - ..., "" . . , . . . :Feedback system () , "" "" . : , . :Down regulation . (" ) "" . :Up regulation. : , ,

, . " .mixed agonist/antagonist :Resurgence .

3 : ) -(CNS , " .BBB ) -(PNS : - ( ), CNS . . - " : -. . . . . , , CNS : CNS -

: 1. - rest & digest . . . . 2. - ,fight or flight . , , " . . . : , - GABA

: . ( + ) " . : " ( " ) . A . ( ). " . / / , . . . * . : , , , . . : 5M1,M2,M3,M4,M 1 -M , ,.gastric parietal cells CNS 2 -M , . 3 -M , . 5.CNS -M4+M

4

, . : -N -C, ,G-protein G-protein GTP . :G-protein 1. - ( ) 2. - , .AMP 3 -Gq C 3 IP . 5 -M1, M3, M G-protein Gq . 4 -M2, M G-protein G-inhibitory : ( ) ).(SA node- Ca .

: , , . " . . . : . ( ). , , , , , , . " . : , ( ), ( ) . :Bethanechol " . . . :Carbachol , . :Pilocarpine , , , , , .CNS : !, , , . . "-" . . : 1. ... Myasthenia gravis 4-2 ... GI , BBB GI ,miosis . CNS Neostigmine Physostigmine

Myasthenia gravis MG

6-3 02-01

Pyridostigmine Edrophonium

2. : ( ). . : , . " .

: , . :Atropine: - GI - - , - . : ( (NN ) (NM , , . : , , . . :Trimethaphan , , . : . : 1. ""- . 2. - , . - . :Non depolarizing agents , . ( ). : , , , , . . , . :Depolarizing agents , ( ) . .

5- : CNS ( )fight or flight : . (.)Varicosities : / . . rate ,limiting step . . , , . " .re uptake ": , " re uptake ,COMT ,symport .Re uptake -MAO-Monoamine Oxidase , : MAO-A . MAO-B . : 2.1,2, 1, 1 : G-protein Gq ( , , , ). ( . 2 : 2 G-protein , , , . 1 : G-protein, , . 2 : , , G-protein, . : up/down regulation :

"" . / . G-protein .

-

: : -: (, ). - - : , , , ,BBB " . : . , - . . " . .: -: 2( ). 1( ) 1( ). . , 1. 2. . : 2. : " . / . : , , , , . : .1 , . . , , , ( ). :Isoproterenol , 2( ) 1( ). : 5 D1-D , 1.D 2 D . . .

: 1D ( , )

1( ) 1

.... (CHF ) AV 1 ( ). , " .

: : 1 Dobutamine

Phenylephrine 2 2 2 Clonidine Terbutaline Albuterol

.... , ,

, MAO CNS Tyramine

: :Ephedrine NA, ,, MAO ,COMT , , CNS . : ( ). . .... 2,1 phechromocytoma Phentolamine phenoxybenzamine 4 (42 ) Phenoxybenzamine 2,1 ,TPR ( " 2 ) 1 TPR Prazosin , . , , , . : postal hypotention : , , , , . .... ( ) propranolol 2 . 2,1 ( . , , , , Hyperthyroidism : , , , , ,Timolol 2,1 Timolo Nadolol

, , , . ,

Pindolol 1 ,Labtalol carvedilol

: -Reserpine NA ". -Guanethidine NA NA " MAO -Cocaine NA .

6- - : : , , 2,CO 2 CO . . : - , .... - - - . SA node , ( ) . SA node ( AV node , ) (0.5 sec AV node ) (0.1 sec . : , . : -Pacemaker cells . -Automaticity . -Non pacemaker cells . -Over drive suppression - , . over drive suppression SA node , . : , , . - " :

0: ( ) " (05+). 1: , . 2: . 3: ( ). 4: , " " , . .. :SA node 4 , . SA node, AV node (06-) ( 06-) (09-) SA node , . SA node , 09- ( 08- %08 06- %5 ) SA node , , . 4,3,0 : / :Na/K ATPase , ( )ER RYR 2 . SERCA (ER ( ER ER ) .

4 ( 2). 4 , . NCX Na/K ATPase . ( Phospholamban 71) SERCA" " ATP .ADP : adrenergic " , G-protein ,cAMP ) PKA (phosphatase kinase , . PKA ( SERCA ) . ER , . cAMP" ( cAMP), cAMP cAMP . %07 cardiac output cardiac output %04. ""- , , , , . " , , 2 : 1. , , . 2. . , - . . , . 4 ( 4 ) . , .

, , , , . . cardiac output , , ": .Remodeling , afterload , preload :Afterload , . :Preload ( ) ( 4), . preload . preload , preload preload cardiac output. preload afterload , cardiac output. preload : : cardiac output , preload. : cardiac output .preload ( : )shock cardiac output ,preload preload ?cardiac output :Afterload ( )A afterload cardiac output cardiac output . ( )C ,afterload () Cardiac output ( )B afterload cardiac output.

: :Inotropic agents : Cardiac glycosides Sympathomimetic amines -Phosphodiesterase inhibitors cAMP PKA , . :Afterload reduction ( .)afterload : ACE inhibitors adrenoceptors antagonists vasodilators -preload reduction preload : ( diuretics ) .Venodilators ( 82) Na/K ATPase . - , , . :Na/K ATPase 4 . , , , , . - , . , .Na/K ATPase "- " .Na/K AT